197 related articles for article (PubMed ID: 31090234)
41. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
[TBL] [Abstract][Full Text] [Related]
42. Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients.
Malyszko J; Malyszko JS; Bachorzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
Transplant Proc; 2009; 41(1):158-61. PubMed ID: 19249502
[TBL] [Abstract][Full Text] [Related]
43. Urinary versus plasma neutrophil gelatinase-associated lipocalin (NGAL) as a predictor of mortality for acute kidney injury in intensive care unit patients.
Mahmoodpoor A; Hamishehkar H; Fattahi V; Sanaie S; Arora P; Nader ND
J Clin Anesth; 2018 Feb; 44():12-17. PubMed ID: 29100016
[TBL] [Abstract][Full Text] [Related]
44. Influence of clinical and experimental intra-articular inflammation on neutrophil gelatinase-associated lipocalin concentrations in horses.
Frydendal C; Nielsen KB; Berg LC; van Galen G; Adler DMT; Andreassen SM; Jacobsen S
Vet Surg; 2021 Apr; 50(3):641-649. PubMed ID: 33522003
[TBL] [Abstract][Full Text] [Related]
45. Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment.
Eilenberg W; Stojkovic S; Piechota-Polanczyk A; Kaider A; Kozakowski N; Weninger WJ; Nanobachvili J; Wojta J; Huk I; Demyanets S; Neumayer C
Cardiovasc Diabetol; 2017 Aug; 16(1):98. PubMed ID: 28789657
[TBL] [Abstract][Full Text] [Related]
46. Elevation of plasma neutrophil gelatinase-associated lipocalin (NGAL) levels in schizophrenia patients.
Wei L; Du Y; Wu W; Fu X; Xia Q
J Affect Disord; 2018 Jan; 226():307-312. PubMed ID: 29028592
[TBL] [Abstract][Full Text] [Related]
47. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
[TBL] [Abstract][Full Text] [Related]
48. Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
Clin Chim Acta; 2018 Nov; 486():66-75. PubMed ID: 30036522
[TBL] [Abstract][Full Text] [Related]
49. Neutrophil gelatinase-associated lipocalin as a risk marker in cardiovascular disease.
Sivalingam Z; Larsen SB; Grove EL; Hvas AM; Kristensen SD; Magnusson NE
Clin Chem Lab Med; 2017 Nov; 56(1):5-18. PubMed ID: 28672731
[TBL] [Abstract][Full Text] [Related]
50. The relationship between serum neutrophil gelatinase-associated lipocalin and renal function in patients with vancomycin treatment.
Park HD; Seo JY; Lee SY
Ann Clin Lab Sci; 2012; 42(1):7-13. PubMed ID: 22371904
[TBL] [Abstract][Full Text] [Related]
51. Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study-Impact for mortality.
Woitas RP; Scharnagl H; Kleber ME; Delgado GE; Grammer TB; Pichler M; Krämer BK; März W; Stojakovic T
PLoS One; 2017; 12(2):e0171574. PubMed ID: 28207778
[TBL] [Abstract][Full Text] [Related]
52. Predictive utilities of neutrophil gelatinase-associated lipocalin (NGAL) in severe sepsis.
Chang W; Zhu S; Pan C; Xie JF; Liu SQ; Qiu HB; Yang Y
Clin Chim Acta; 2018 Jun; 481():200-206. PubMed ID: 29572184
[TBL] [Abstract][Full Text] [Related]
53. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
54. The clinical significance of neutrophil gelatinase-associated lipocalin in ischemic stroke patients with acute kidney injury.
Xiao W; Chen W; Hu H; Huang X; Luo Y
J Clin Lab Anal; 2019 Jul; 33(6):e22907. PubMed ID: 31062866
[TBL] [Abstract][Full Text] [Related]
55. Urinalysis is more specific and urinary neutrophil gelatinase-associated lipocalin is more sensitive for early detection of acute kidney injury.
Schinstock CA; Semret MH; Wagner SJ; Borland TM; Bryant SC; Kashani KB; Larson TS; Lieske JC
Nephrol Dial Transplant; 2013 May; 28(5):1175-85. PubMed ID: 22529161
[TBL] [Abstract][Full Text] [Related]
56. Association of plasma neutrophil gelatinase-associated lipocalin with acute kidney injury and clinical outcome in cardiac arrest survivors depends on the time of measurement.
Cho YS; Lee BK; Lee DH; Jung YH; Lee SM; Park JS; Jeung KW
Biomarkers; 2018 Jul; 23(5):487-494. PubMed ID: 29533106
[TBL] [Abstract][Full Text] [Related]
57. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
58. Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
Cullaro G; Kim G; Pereira MR; Brown RS; Verna EC
Dig Dis Sci; 2017 Dec; 62(12):3487-3494. PubMed ID: 29098551
[TBL] [Abstract][Full Text] [Related]
59. Plasma neutrophil gelatinase-associated lipocalin as a biomarker for acute kidney injury in critically ill patients with suspected sepsis.
Kim H; Hur M; Cruz DN; Moon HW; Yun YM
Clin Biochem; 2013 Oct; 46(15):1414-8. PubMed ID: 23747960
[TBL] [Abstract][Full Text] [Related]
60. Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure.
Yndestad A; Landrø L; Ueland T; Dahl CP; Flo TH; Vinge LE; Espevik T; Frøland SS; Husberg C; Christensen G; Dickstein K; Kjekshus J; Øie E; Gullestad L; Aukrust P
Eur Heart J; 2009 May; 30(10):1229-36. PubMed ID: 19329498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
